ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

MICHELLE JENKINS M.D.

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,219Medicare Part D Prescriptions Filled, Including Refills

Rank: 393 out of 1677

$525K Total Retail Price of All Prescriptions

Rank: 337 out of 1677

702 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,586 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 484 443 1 5
PRAVASTATIN SODIUM 340 312 2 10
SIMVASTATIN 267 241 3 1
AMLODIPINE BESYLATE 251 247 4 2
OMEPRAZOLE 247 235 5 6
ATORVASTATIN CALCIUM 240 221 6 13
LISINOPRIL 235 215 7 3
HYDROCHLOROTHIAZIDE 200 190 8 9
METFORMIN HCL 196 172 9 7
SYNTHROID 179 177 10 55
TRAMADOL HCL 167 161 11 16
GABAPENTIN 166 147 12 11
ZOLPIDEM TARTRATE 166 162 12 15
METOPROLOL SUCCINATE 163 159 14 23
SERTRALINE HCL 149 135 15 26
LOSARTAN POTASSIUM 131 124 16 25
FUROSEMIDE 128 127 17 8
FLUTICASONE PROPIONATE 127 119 18 29
ATENOLOL 124 120 19 21
CITALOPRAM HBR 116 104 20 22
CRESTOR 105 103 21 28
TRIAMTERENE-HCTZ 102 76 22 61
LOVASTATIN 102 98 22 35
NEXIUM 98 90 24 19
HYDROCODONE-ACETAMINOPHEN 91 84 S3 25 4
AMITRIPTYLINE HCL 89 86 R 26 63
LISINOPRIL-HYDROCHLOROTHIAZIDE 86 82 27 17
LOSARTAN-HYDROCHLOROTHIAZIDE 84 78 28 42
METOPROLOL TARTRATE 79 74 29 12
CARVEDILOL 79 77 29 20
FLUOXETINE HCL 75 75 31 49
DIOVAN 73 71 32 45
MELOXICAM 73 67 32 27
ALENDRONATE SODIUM 70 70 34 43
WARFARIN SODIUM 70 70 34 24
AZITHROMYCIN 65 59 36 38
PREDNISONE 62 60 37 40
NAMENDA 58 58 38 39
ZETIA 58 58 38 75
PANTOPRAZOLE SODIUM 54 53 40 46
METHYLPREDNISOLONE 52 45 41 145
OXYBUTYNIN CHLORIDE ER 51 51 42 173
PAROXETINE HCL 51 45 42 67
ALLOPURINOL 50 50 44 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.